# Neuromodulation and Language Acquisition (Stage Ib)

> **NCT00102856** · PHASE4 · SUSPENDED · sponsor: **University Hospital Muenster** · enrollment: 60 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pramipexole
- **DRUG:** Rivastigmine

## Key facts

- **NCT ID:** NCT00102856
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2005-01
- **Primary completion:** —
- **Final completion:** 2006-06
- **Target enrollment:** 60 (—)
- **Last updated:** 2010-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00102856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00102856, "Neuromodulation and Language Acquisition (Stage Ib)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00102856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*